Related references
Note: Only part of the references are listed.Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma
Adrian M. Dubuc et al.
ACTA NEUROPATHOLOGICA (2013)
Biological and clinical heterogeneity of MYCN-amplified medulloblastoma
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2012)
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
Paul A. Northcott et al.
ACTA NEUROPATHOLOGICA (2012)
Molecular subgroups of medulloblastoma: the current consensus
Michael D. Taylor et al.
ACTA NEUROPATHOLOGICA (2012)
Subgroup-specific alternative splicing in medulloblastoma
Adrian M. Dubuc et al.
ACTA NEUROPATHOLOGICA (2012)
Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem
Daniel Grammel et al.
ACTA NEUROPATHOLOGICA (2012)
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Marcel Kool et al.
ACTA NEUROPATHOLOGICA (2012)
Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYC
Fredrik J. Swartling et al.
CANCER CELL (2012)
CXCR4 Activation Defines a New Subgroup of Sonic Hedgehog-Driven Medulloblastoma
Rajarshi Sengupta et al.
CANCER RESEARCH (2012)
Functional Genomics Identifies Drivers of Medulloblastoma Dissemination
Michael Mumert et al.
CANCER RESEARCH (2012)
Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations
Tobias Rausch et al.
CELL (2012)
WNT signaling increases proliferation and impairs differentiation of stem cells in the developing cerebellum
Yanxin Pei et al.
DEVELOPMENT (2012)
Molecular subgroups of medulloblastoma
Paul A. Northcott et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
Targeting the enhancer of zeste homologue 2 in medulloblastoma
Irina Alimova et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Trevor J. Pugh et al.
NATURE (2012)
Novel mutations target distinct subgroups of medulloblastoma
Giles Robinson et al.
NATURE (2012)
Dissecting the genomic complexity underlying medulloblastoma
David T. W. Jones et al.
NATURE (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Clonal selection drives genetic divergence of metastatic medulloblastoma
Xiaochong Wu et al.
NATURE (2012)
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott et al.
NATURE (2012)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20052009
Therese A. Dolecek et al.
NEURO-ONCOLOGY (2012)
Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells
X. Wang et al.
ONCOGENE (2012)
Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response
Nicholas J. Szerlip et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma
Karen M. Mann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Medulloblastomics: the end of the beginning
Paul A. Northcott et al.
NATURE REVIEWS CANCER (2012)
Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct
Paul A. Northcott et al.
ACTA NEUROPATHOLOGICA (2011)
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
David W. Ellison et al.
ACTA NEUROPATHOLOGICA (2011)
Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma
Matija Snuderl et al.
CANCER CELL (2011)
Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma
Hendrik Witt et al.
CANCER CELL (2011)
Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug Resistance
Gerrit J. P. Dijkgraaf et al.
CANCER RESEARCH (2011)
PCDH10 is a candidate tumour suppressor gene in medulloblastoma
Kelsey C. Bertrand et al.
CHILDS NERVOUS SYSTEM (2011)
Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma
Ingrid Slade et al.
FAMILIAL CANCER (2011)
Adult Medulloblastoma Comprises Three Major Molecular Variants
Marc Remke et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
FSTL5 Is a Marker of Poor Prognosis in Non-WNT/Non-SHH Medulloblastoma
Marc Remke et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
Yoon-Jae Cho et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
TP53 Mutations in Favorable-Risk Wnt/Wingless-Subtype Medulloblastomas
Janet C. Lindsey et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Challenging issues in pediatric oncology
Ching-Hon Pui et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
The Genetic Landscape of the Childhood Cancer Medulloblastoma
D. Williams Parsons et al.
SCIENCE (2011)
FISH and chips: the recipe for improved prognostication and outcomes for children with medulloblastoma
Vijay Ramaswamy et al.
CANCER GENETICS (2011)
A decade of exploring the cancer epigenome - biological and translational implications
Stephen B. Baylin et al.
NATURE REVIEWS CANCER (2011)
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Houtan Noushmehr et al.
CANCER CELL (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
The Genetics of Pediatric Brain Tumors
Adrian M. Dubuc et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2010)
Calculating a cure for cancer: managing medulloblastoma MATH1-ematically
Adrian M. Dubuc et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Survival and Prognostic Factors of Early Childhood Medulloblastoma: An International Meta-Analysis
Stefan Rutkowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Subtypes of medulloblastoma have distinct developmental origins
Paul Gibson et al.
NATURE (2010)
Advances in understanding cancer genomes through second-generation sequencing
Matthew Meyerson et al.
NATURE REVIEWS GENETICS (2010)
Genomics of medulloblastoma: from Giemsa-banding to next-generation sequencing in 20 years
Paul A. Northcott et al.
NEUROSURGICAL FOCUS (2010)
A pathway-based classification of human breast cancer
Michael L. Gatza et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma
Silvia Buonamici et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
The miR-17/92 Polycistron Is Up-regulated in Sonic Hedgehog-Driven Medulloblastomas and Induced by N-myc in Sonic Hedgehog-Treated Cerebellar Neural Precursors
Paul A. Northcott et al.
CANCER RESEARCH (2009)
Psychological Status in Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study
Lonnie K. Zeltzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma
Paul A. Northcott et al.
NATURE GENETICS (2009)
Brief Report: Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449.
Charles M. Rudin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
被撤回的出版物: Requirement for chromatin-remodeling complex in novel tumor suppressor HIC1-mediated transcriptional repression and growth control (Retracted article. See vol. 30, pg. 4374, 2011)
B. Zhang et al.
ONCOGENE (2009)
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Robert L. Yauch et al.
SCIENCE (2009)
Management of and Prognosis With Medulloblastoma Therapy at a Crossroads
Roger J. Packer et al.
ARCHIVES OF NEUROLOGY (2008)
Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma
Ulrich Schueller et al.
CANCER CELL (2008)
Medulloblastoma can be initiated by deletion of patched in lineage-restricted progenitors or stem cells
Zeng-Jie Yang et al.
CANCER CELL (2008)
An Epigenetic Genome-Wide Screen Identifies SPINT2 as a Novel Tumor Suppressor Gene in Pediatric Medulloblastoma
Paul N. Kongkham et al.
CANCER RESEARCH (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
Marcel Kool et al.
PLOS ONE (2008)
Medulloblastoma in childhood: new biological advances
John R. Crawford et al.
LANCET NEUROLOGY (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis
Steven C. Clifford et al.
CELL CYCLE (2006)
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
Amar Gajjar et al.
LANCET ONCOLOGY (2006)
Synphilin isoforms and the search for a cellular model of Lewy body formation in Parkinson's disease
Allon Eyal et al.
CELL CYCLE (2006)
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma
Roger J. Packer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Genornics identifies medulloblastoma subgroups that are enriched for specific genetic alterations
MC Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse
LS Collier et al.
NATURE (2005)
Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system
AJ Dupuy et al.
NATURE (2005)
Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma
TG Oliver et al.
DEVELOPMENT (2005)
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone
S Rutkowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clinical, histopathologic, and molecular markers of prognosis: Toward a new disease risk stratification system for medulloblastoma
A Gajjar et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas
AR Hallahan et al.
CANCER RESEARCH (2004)
Health status of adult long-term survivors of childhood cancer - A report from the childhood cancer survivor study
MM Hudson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Medulloblastoma: Present concepts of stratification into risk groups
RJ Packer et al.
PEDIATRIC NEUROSURGERY (2003)
Mutations in SUFU predispose to medulloblastoma
MD Taylor et al.
NATURE GENETICS (2002)
Prediction of central nervous system embryonal tumour outcome based on gene expression
SL Pomeroy et al.
NATURE (2002)
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
A Bhattacharjee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping
J Bayani et al.
JOURNAL OF NEUROSURGERY (2000)